Proposed Mechanism of Action (MOA) | OCREVUS® (ocrelizumab)
Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis | SpringerLink
The mechanism of action of glatiramer acetate in multiple sclerosis and beyond - ScienceDirect
Sphingosine-1-phosphate Receptor Modulators in Multiple Sclerosis | touchNEUROLOGY
From Natural Product to the First Oral Treatment for Multiple Sclerosis: The Discovery of FTY720 (Gilenya™)? - ScienceDirect
Fingolimod in multiple sclerosis: Mechanisms of action and clinical efficacy - ScienceDirect
Glatiramer acetate in multiple sclerosis: update on potential mechanisms of action - The Lancet Neurology
Cells | Free Full-Text | Lymphocyte Counts and Multiple Sclerosis Therapeutics: Between Mechanisms of Action and Treatment-Limiting Side Effects | HTML
Multiple sclerosis | Neurology Clinical Practice
Fingolimod is a potential novel therapy for multiple sclerosis | Nature Reviews Neurology
Oral Therapies in MS: Changing the Care Paradigm (Transcript)
Mechanism of action of S1P and fingolimod-P. (a) In physiological... | Download Scientific Diagram
Fingolimod for Multiple Sclerosis | NEJM
IJMS | Free Full-Text | The First Dose of Fingolimod Affects Circulating Extracellular Vesicles in Multiple Sclerosis Patients | HTML
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis | Nature Reviews Drug Discovery
Cardiac and vascular effects of fingolimod: Mechanistic basis and clinical implications - ScienceDirect
References in Emerging injectable therapies for multiple sclerosis - The Lancet Neurology
Emerging multiple sclerosis oral therapies | Neurology
The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis | SpringerLink
Monoclonal Antibody Therapy in Multiple Sclerosis - Practical Neurology
Frontiers | Mechanism of Action and Clinical Potential of Fingolimod for the Treatment of Stroke | Neurology
A Mechanistically Novel, First Oral Therapy for Multiple Sclerosis: The Development of Fingolimod (FTY720, Gilenya) - Jerold Chun - Discovery Medicine
Frontiers | Multiple Sclerosis, Relapses, and the Mechanism of Action of Adrenocorticotropic Hormone | Neurology
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis | Nature Reviews Drug Discovery
